FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304080330> ?p ?o ?g. }

• W4304080330 endingPage "5454" @default.
• W4304080330 startingPage "5440" @default.
• W4304080330 abstract "Abstract Purpose: Small molecule drug conjugates (SMDC) are modular anticancer prodrugs that include a tumor-targeting small organic ligand, a cleavable linker, and a potent cytotoxic agent. Most of the SMDC products that have been developed for clinical applications target internalizing tumor-associated antigens on the surface of tumor cells. We have recently described a novel non-internalizing small organic ligand (named OncoFAP) of fibroblast activation protein (FAP), a tumor-associated antigen highly expressed in the stroma of most solid human malignancies. Experimental Design: In this article, we describe a new series of OncoFAP-Drug derivatives based on monomethyl auristatin E (MMAE; a potent cytotoxic tubulin poison) and dipeptide linkers that are selectively cleaved by FAP in the tumor microenvironment. Results: The tumor-targeting potential of OncoFAP was confirmed in patients with cancer using nuclear medicine procedures. We used mass spectrometry methodologies to quantify the amount of prodrug delivered to tumors and normal organs, as well as the efficiency of the drug release process. Linkers previously exploited for anticancer drug conjugates were used as benchmark. We identified OncoFAP-Gly-Pro-MMAE as the best performing SMDC, which has now been prioritized for further clinical development. OncoFAP-Gly-Pro-MMAE selectively delivered more than 10% injected dose per gram of MMAE to FAP-positive tumors, with a tumor-to-kidney ratio of 16:1 at 24 hours post-injection. Conclusions: The FAP-specific drug conjugates described in this article promise to be efficacious for the targeting of human malignancies. The extracellular release of potent anticancer payloads mediates durable complete remission in difficult-to-treat animal models of cancer." @default.
• W4304080330 created "2022-10-10" @default.
• W4304080330 creator A5000854921 @default.
• W4304080330 creator A5005230318 @default.
• W4304080330 creator A5007953180 @default.
• W4304080330 creator A5011462995 @default.
• W4304080330 creator A5017038984 @default.
• W4304080330 creator A5020168745 @default.
• W4304080330 creator A5023255344 @default.
• W4304080330 creator A5027100001 @default.
• W4304080330 creator A5033238501 @default.
• W4304080330 creator A5034291688 @default.
• W4304080330 creator A5036925467 @default.
• W4304080330 creator A5037557607 @default.
• W4304080330 creator A5038084150 @default.
• W4304080330 creator A5040869028 @default.
• W4304080330 creator A5066799995 @default.
• W4304080330 creator A5072080476 @default.
• W4304080330 creator A5081242885 @default.
• W4304080330 date "2022-10-10" @default.
• W4304080330 modified "2023-10-03" @default.
• W4304080330 title "Fibroblast Activation Protein Triggers Release of Drug Payload from Non-internalizing Small Molecule Drug Conjugates in Solid Tumors" @default.
• W4304080330 cites W1980378174 @default.
• W4304080330 cites W1991883406 @default.
• W4304080330 cites W2013959082 @default.
• W4304080330 cites W2017800162 @default.
• W4304080330 cites W2027361123 @default.
• W4304080330 cites W2029838406 @default.
• W4304080330 cites W2084013867 @default.
• W4304080330 cites W2094288422 @default.
• W4304080330 cites W2097820456 @default.
• W4304080330 cites W2122866527 @default.
• W4304080330 cites W2139429843 @default.
• W4304080330 cites W2150594642 @default.
• W4304080330 cites W2152673204 @default.
• W4304080330 cites W2231446168 @default.
• W4304080330 cites W2288867196 @default.
• W4304080330 cites W2314772071 @default.
• W4304080330 cites W2337811195 @default.
• W4304080330 cites W2416068441 @default.
• W4304080330 cites W2510341570 @default.
• W4304080330 cites W2531611585 @default.
• W4304080330 cites W2555639097 @default.
• W4304080330 cites W2764118186 @default.
• W4304080330 cites W2783268592 @default.
• W4304080330 cites W2796422399 @default.
• W4304080330 cites W2796437750 @default.
• W4304080330 cites W2885479861 @default.
• W4304080330 cites W2904790990 @default.
• W4304080330 cites W2921110418 @default.
• W4304080330 cites W2930582547 @default.
• W4304080330 cites W2950613960 @default.
• W4304080330 cites W2963176372 @default.
• W4304080330 cites W2982411421 @default.
• W4304080330 cites W2999544576 @default.
• W4304080330 cites W3008784786 @default.
• W4304080330 cites W3009586897 @default.
• W4304080330 cites W3009885756 @default.
• W4304080330 cites W3010970122 @default.
• W4304080330 cites W3012741718 @default.
• W4304080330 cites W3021215586 @default.
• W4304080330 cites W3024421136 @default.
• W4304080330 cites W3028656232 @default.
• W4304080330 cites W3035644303 @default.
• W4304080330 cites W3037670955 @default.
• W4304080330 cites W3082903212 @default.
• W4304080330 cites W3091732410 @default.
• W4304080330 cites W3122689398 @default.
• W4304080330 cites W3129624046 @default.
• W4304080330 cites W3134752697 @default.
• W4304080330 cites W3138613607 @default.
• W4304080330 cites W3156123897 @default.
• W4304080330 cites W3162173869 @default.
• W4304080330 cites W3163091095 @default.
• W4304080330 cites W3171924744 @default.
• W4304080330 cites W3204247219 @default.
• W4304080330 cites W3205072810 @default.
• W4304080330 cites W3210491826 @default.
• W4304080330 cites W4200570830 @default.
• W4304080330 cites W4206583229 @default.
• W4304080330 cites W4225366649 @default.
• W4304080330 doi "https://doi.org/10.1158/1078-0432.ccr-22-1788" @default.
• W4304080330 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36215129" @default.
• W4304080330 hasPublicationYear "2022" @default.
• W4304080330 type Work @default.
• W4304080330 citedByCount "3" @default.
• W4304080330 countsByYear W43040803302023 @default.
• W4304080330 crossrefType "journal-article" @default.
• W4304080330 hasAuthorship W4304080330A5000854921 @default.
• W4304080330 hasAuthorship W4304080330A5005230318 @default.
• W4304080330 hasAuthorship W4304080330A5007953180 @default.
• W4304080330 hasAuthorship W4304080330A5011462995 @default.
• W4304080330 hasAuthorship W4304080330A5017038984 @default.
• W4304080330 hasAuthorship W4304080330A5020168745 @default.
• W4304080330 hasAuthorship W4304080330A5023255344 @default.
• W4304080330 hasAuthorship W4304080330A5027100001 @default.
• W4304080330 hasAuthorship W4304080330A5033238501 @default.
• W4304080330 hasAuthorship W4304080330A5034291688 @default.

• next